Seagen upgraded by Evercore ISI with a new price target
$SGEN
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Evercore ISI upgraded Seagen from In-line to Outperform and set a new price target of $175.00 from $140.00 previously